Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Study Shows Women With Breast Cancer Treated With Radiotherapy Using Tangential Fields Have Increased Risk Of Developing Cancer In The Other Breast
http://www.medicalnewstoday.com/articles/128039.php
Women with breast cancer treated with radiotherapy using tangential fields - where radiation is directed at an angle to the breast - after lumpectomy show increased risk of breast cancer in the other breast, with an even higher risk in younger women and in those with family members who have had breast cancer, warns a study.
New Study Finds Many Breast Cancer Patients Are Not Receiving The Most Advanced Breast Conserving Surgical Techniques
http://www.medicalnewstoday.com/articles/127987.php
New surgical techniques have dramatically improved the aesthetic results of mastectomy without sacrificing outcomes. Properly placed incisions and skin-sparing, or breast skin conserving, surgical approaches provide women undergoing biopsy and surgical treatment for breast cancer with the best option for appropriate cancer eradication while still permitting reconstruction of a more natural looking breast.
----------------------------------------------
** CANCER / ONCOLOGY News **
Akorn-Strides, LLC Announces FDA Approval For Pamidronate Disodium Injection, 3 Mg/mL And 9 Mg/mL
http://www.medicalnewstoday.com/articles/128136.php
Akorn-Strides, LLC today announced that the U.S. Food and Drug Administration has granted approval for an Abbreviated New Drug Application (ANDA) for Pamidronate Disodium Injection, 3 mg/mL and 9 mg/mL in 10 mL vials.
Multiple Myeloma Research Foundation's Annual Gala Raises More Than $1.5 Million To Advance Cancer Research
http://www.medicalnewstoday.com/articles/128125.php
The Multiple Myeloma Research Foundation (MMRF) raised over $1.5 million at its 12th annual "Friends for Life" Fall Gala held on November 1, 2008 in Greenwich, Conn. Funds raised at this premier fundraiser, attended by more than 900 guests will support the MMRF's innovative research portfolio developed to bring patients new treatments and find a cure for multiple myeloma, a fatal blood cancer.
DxS K-RAS Mutation Detection Assays Will Assist US Oncologists In Studying Patient Response To Cancer Therapies In Clinical Trials
http://www.medicalnewstoday.com/articles/128069.php
DxS Ltd, a personalised medicine company and leader in the provision of companion diagnostics, have today announced an agreement with US-based Oncology diagnostic and biopharmaceutical services company AltheaDx, Inc.
Half-Broken Gene Is Enough To Cause Cancer
http://www.medicalnewstoday.com/articles/128041.php
Tumour suppressor genes do not necessarily require both alleles to be knocked out before disease phenotypes are expressed. Research published in BioMed Central's new open access journal <i>PathoGenetics</i> reveals that only one allele of SMAD4 has to be damaged to put a person at risk of pancreatic and colorectal cancer.
Discovery Of Markers For Esophageal Cancer Before It Develops
http://www.medicalnewstoday.com/articles/128040.php
Rhode Island Hospital researchers have identified genetic proteins, also known as biomarkers, capable of distinguishing changes at the microscopic level that can signal a precancerous condition in the esophagus.
Cancer Vaccine - Study Analyzed At Southern Research Institute Shows Human Antibodies Generated By Canopus's Peptides Have Anti-Cancer Properties
http://www.medicalnewstoday.com/articles/128028.php
Canopus BioPharma, Inc. (OTC: CBIA) today announced that it has successfully completed the second phase of its cancer vaccine development. The specialized laboratory study was analyzed at the Southern Research Institute in Birmingham, Alabama.
Effective HPV Vaccine For Women And Men And A Simple HPV Screening Test Recommended By Researchers
http://www.medicalnewstoday.com/articles/128020.php
A call to explore a broader use of HPV (human papillomavirus) vaccines and the validation of a simple oral screening test for HPV-caused oral cancers are reported in two studies by a Johns Hopkins Kimmel Cancer Center investigator.
$8.6 Million NIH Grant Awarded To Center For Health Enhancement Systems Studies
http://www.medicalnewstoday.com/articles/128009.php
The Center for Health Enhancement Systems Studies (CHESS) has been awarded a second grant from the National Cancer Institute, (NCI) a division of the National Institutes of Health (NIH), to continue its role as a leader in cancer communication research.
Fighting Neuroblastoma: VA Double-Barreled Immune Cell Approach
http://www.medicalnewstoday.com/articles/127997.php
Adding an artificial tumor-specific receptor to immune system cells called T-lymphocytes that target a particular virus extended and improved the cells' ability to fight a form of childhood cancer called neuroblastoma, said researchers form Baylor College of Medicine and Texas Children's Hospital in a report that appears online today in the journal<i> Nature Medicine.
A Single 'Designer Molecule' Tackles Skin Cancer Cells By 2 Completely Different Routes
http://www.medicalnewstoday.com/articles/127988.php
By playing it safe and using a two-pronged attack, a novel designer molecule fights malignant melanoma. It was created and tested by an international team of researchers led by the University of Bonn.
New Study Finds Many Breast Cancer Patients Are Not Receiving The Most Advanced Breast Conserving Surgical Techniques
http://www.medicalnewstoday.com/articles/127987.php
New surgical techniques have dramatically improved the aesthetic results of mastectomy without sacrificing outcomes. Properly placed incisions and skin-sparing, or breast skin conserving, surgical approaches provide women undergoing biopsy and surgical treatment for breast cancer with the best option for appropriate cancer eradication while still permitting reconstruction of a more natural looking breast.
About 50% Of Men And 30% Of Women In The USA Will Receive A Cancer Diagnosis During Their Lifetimes. Tips For Newly-diagnosed Patients
http://www.medicalnewstoday.com/articles/127984.php
About one-half of men and one-third of women in the United States will receive a cancer diagnosis during their lifetimes. That diagnosis often comes with little warning. After a cancer diagnosis, patients may feel anxious, afraid or overwhelmed and wonder how they can cope during the days to come.
California Colorectal Cancer Coalition Holds Its First Community Forum To Save Lives By Promoting And Advocating For Colorectal Cancer Screening
http://www.medicalnewstoday.com/articles/127980.php
To prevent more deaths and suffering from the third most common cancer in California, the California Colorectal Cancer Coalition (C4) <a href="http://cacoloncancer.org/" target="_blank" rel="nofollow">http://cacoloncancer.
Linda Creed Awarded American Cancer Society's Project Award
http://www.medicalnewstoday.com/articles/127975.php
Linda Creed, an affiliate of Public Health Management Corporation (PHMC), was recently awarded the American Cancer Society's Project Award for their program "A Day in the Life of the Breast Cancer Research Laboratory…A Workshop for Breast Cancer Advocates.
CuraGen Announces Preliminary Data From Ongoing Phase II Study Showing Clinical Activity Of CR011-vcMMAE In Patients With Metastatic Melanoma
http://www.medicalnewstoday.com/articles/127969.php
CuraGen Corporation (Nasdaq: CRGN) announced preliminary data from an ongoing Phase II trial of CR011-vcMMAE, an antibody-drug conjugate that targets GPNMB, for the treatment of patients with unresectable Stage III or Stage IV melanoma.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Effective HPV Vaccine For Women And Men And A Simple HPV Screening Test Recommended By Researchers
http://www.medicalnewstoday.com/articles/128020.php
A call to explore a broader use of HPV (human papillomavirus) vaccines and the validation of a simple oral screening test for HPV-caused oral cancers are reported in two studies by a Johns Hopkins Kimmel Cancer Center investigator.
----------------------------------------------
** COLORECTAL CANCER News **
Small Colon Polyps: Surgical Removal Is Costly And Unnecessary
http://www.medicalnewstoday.com/articles/128119.php
Polypectomy (the surgical removal of polyps by colonoscopy) of small polyps found during CT colonography is costly and unnecessary according to a study performed at the University of Wisconsin School of Medicine and Public Health in Madison, WI.
Half-Broken Gene Is Enough To Cause Cancer
http://www.medicalnewstoday.com/articles/128041.php
Tumour suppressor genes do not necessarily require both alleles to be knocked out before disease phenotypes are expressed. Research published in BioMed Central's new open access journal <i>PathoGenetics</i> reveals that only one allele of SMAD4 has to be damaged to put a person at risk of pancreatic and colorectal cancer.
California Colorectal Cancer Coalition Holds Its First Community Forum To Save Lives By Promoting And Advocating For Colorectal Cancer Screening
http://www.medicalnewstoday.com/articles/127980.php
To prevent more deaths and suffering from the third most common cancer in California, the California Colorectal Cancer Coalition (C4) <a href="http://cacoloncancer.org/" target="_blank" rel="nofollow">http://cacoloncancer.
----------------------------------------------
** LUNG CANCER News **
Lung Cancer - Early Detection Saves Lives, Isle Of Wight NHS Primary Care Trust, UK
http://www.medicalnewstoday.com/articles/127999.php
If you have a cough that won't go away, feel out of breath and more tired than normal or have lost weight but don't know why - see your doctor straight away as it could be the early signs of lung cancer.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Multiple Myeloma Research Foundation's Annual Gala Raises More Than $1.5 Million To Advance Cancer Research
http://www.medicalnewstoday.com/articles/128125.php
The Multiple Myeloma Research Foundation (MMRF) raised over $1.5 million at its 12th annual "Friends for Life" Fall Gala held on November 1, 2008 in Greenwich, Conn. Funds raised at this premier fundraiser, attended by more than 900 guests will support the MMRF's innovative research portfolio developed to bring patients new treatments and find a cure for multiple myeloma, a fatal blood cancer.
Histone Methylation As Distinguishing Feature For Leukemia Subtypes Highlighted By Mouse Model
http://www.medicalnewstoday.com/articles/128056.php
Research using a new mouse model has led to the identification of a potential therapeutic target for a type of leukemia commonly associated with an unfavorable prognosis. The study, published by Cell Press in the November issue of the journal <i>Cancer Cell,</i> also validates examination of histone modification as a strategy for distinguishing cancer subtypes.
Increased Cancer Risk Following Liver Transplant
http://www.medicalnewstoday.com/articles/128027.php
A new Canadian study comparing cancer rates of liver transplant patients to those of the general population has found that transplant recipients face increased risks of developing cancer, especially non-Hodgkin's lymphoma and colorectal cancer.
Novel Leukemia Vaccine For High-Risk Patients Studied At Moores UCSD Cancer Center
http://www.medicalnewstoday.com/articles/128024.php
Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia.
Cell Therapeutics Announces Study Data Set Cut-off For Phase III Pivotal Pixantrone (301) Trial
http://www.medicalnewstoday.com/articles/127970.php
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that it has closed the data set for preliminary analysis of the primary endpoint in the phase III EXTEND (PIX301) trial of pixantrone (BBR2278) for patients with relapsed diffuse large B cell non-Hodgkin's lymphoma (NHL) and it has provided Novartis notice that the data set has been closed.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment